Elvie
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Elvie - overview
Established
2013
Location
London, England, UK
Primary Industry
Consumer Products
About
Elvie is a pioneering company developing innovative femtech products that enhance women's health, particularly in breastfeeding solutions, aiming to provide convenience and discretion for nursing mothers. Founded in 2013 in London, UK, Elvie specializes in creating advanced breastfeeding solutions for women. The company has accomplished 7 deals, with its most recent funding round being Series C, raising GBP 12. 7 mn led by Blume Equity.
Founder Tania Boler has an extensive background in health technology, having previously worked with various health initiatives. Elvie's headquarters is in London, and it has made notable advancements in the femtech industry. Elvie offers innovative breastfeeding solutions focused on enhancing mobility and discretion for women. Its flagship products include the Elvie Pump and Elvie Stride, both wearable breast pumps equipped with smart technology.
Additionally, Elvie provides the Elvie Trainer, a smart pelvic floor exerciser. These products are tailored for nursing mothers, aiming to ease challenges during breastfeeding, particularly in professional environments, and are available in markets such as the United States, the United Kingdom, Germany, and France. In 2021, Elvie generated revenue of GBP 89. 08 mn, with an EBITDA of GBP -28.
13 mn. Revenue is driven through direct-to-consumer sales of its product range, including the Elvie Pump and various accessories, which are marketed with promotional offers to enhance customer engagement and loyalty. In March 2025, Elvie was acquired by Willow Innovations, Inc. , aiming to integrate its femtech solutions with Willow's medical device technology to enhance maternal health offerings.
The company's growth strategy includes launching new products and expanding into additional geographical markets. Funding from the recent acquisition will support these initiatives, further positioning Elvie within the maternal health market.
Current Investors
Octopus Investments, AllBright., Impact Ventures UK
Primary Industry
Consumer Products
Sub Industries
Consumer Electronics, Therapeutic Devices, Monitoring Equipment
Website
www.elvie.com/en-us
Verticals
HealthTech, Mobile Apps, Wearables & Quantified Self
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Elvie - timeline of key events

Elvie - financials
| Fiscal Year Ended | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 |
|---|---|---|---|
| Revenue (USD) | - | - | - |
| % Revenue Growth (YoY) | - | - | - |
| EBITDA (USD) | - | - | - |
| Operating Income (USD) | - | - | - |
| Operating Margin | - | - | - |
| % EBITDA Margin | - | - | - |
| NET Income (USD) | - | - | - |
| % Net Margin | - | - | - |
Elvie - employee data


Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.